{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:07:20Z","timestamp":1785424040847,"version":"3.56.0"},"reference-count":36,"publisher":"American Association for Cancer Research (AACR)","issue":"6","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","award":["CCG0197"],"award-info":[{"award-number":["CCG0197"]}],"id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To address the lack of federal screening guidelines and a limited understanding of multiple myeloma among the public and some primary care providers, we created the first community-based multiple myeloma screening program and educational intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>The academic cancer center partnered with community organizations to distribute an original brochure about multiple myeloma, draw blood to check for monoclonal protein, and survey screening participants about multiple myeloma knowledge and screening experiences. Any Black individual aged 50 or older was eligible. To examine multiple myeloma knowledge retention, study team members surveyed participants after at least 1 week had passed and screening results had been provided. The educational intervention also included continuing medical education (CME) about the early detection of multiple myeloma for healthcare professionals. Analysis utilized descriptive statistics and the McNemar test to assess differences between the initial and follow-up surveys.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>From 2023 to 2024, across 22 screening events, 199 participants completed the screening. Among the 158 individuals who completed both surveys, correct responses increased on all items and increased significantly on items about multiple myeloma being a rare cancer of the blood (19%, P &amp;lt; 0.0001) and that individuals with monoclonal gammopathy of undetermined significance (MGUS) have an abnormal protein in the blood (12.1%, P = 0.002). Screening results identified 21 participants (11%) with MGUS. Forty-six healthcare providers engaged in three CME seminars.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Participants retained knowledge about multiple myeloma gained during the screening. Improved health literacy about cancer risk for multiple myeloma may improve early detection, communication, and decision-making about cancer care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study reveals that community members are receptive to multiple myeloma screening when healthcare professionals communicate with them about their risks and share knowledge about disease symptoms and incidence. Improved health literacy about cancer risk for multiple myeloma may improve early detection, communication, and decision-making about cancer care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-26-0056","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:05:37Z","timestamp":1780513537000},"page":"1486-1494","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple Myeloma Screening Education: A Community-Based Health Literacy Intervention"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9711-1490","authenticated-orcid":false,"given":"Karie","family":"Feldman","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9593-919X","authenticated-orcid":false,"given":"Hong","family":"Li","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6984-9684","authenticated-orcid":false,"given":"Diana","family":"Basali","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6914-7439","authenticated-orcid":false,"given":"Faiz","family":"Anwer","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3484-0712","authenticated-orcid":false,"given":"Kimberly","family":"Bell","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8153-0438","authenticated-orcid":false,"given":"Beth","family":"Faiman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4135-6859","authenticated-orcid":false,"suffix":"II","given":"Raymond D.","family":"Jackson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7548-0705","authenticated-orcid":false,"given":"Sandra","family":"Mazzoni","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0375-5747","authenticated-orcid":false,"given":"Kayona","family":"Moore","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9448-5148","authenticated-orcid":false,"given":"Natasha","family":"Patel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2739-2265","authenticated-orcid":false,"given":"Shahzad","family":"Raza","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5605-7020","authenticated-orcid":false,"given":"Jason","family":"Valent","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1725-5355","authenticated-orcid":false,"given":"Heather McKee","family":"Hurwitz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Cancer Institute, , Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"2026062404523989700_bib1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/jnci\/djae321","article-title":"The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045","volume":"117","author":"Mafra","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"2026062404523989700_bib2","volume-title":"Cancer stat facts: myeloma. Bethesda (MD)","author":"National Cancer Institute Surveillance Epidemiology, and End Results Program","year":"2025"},{"key":"2026062404523989700_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcm077","article-title":"Multiple myeloma: causes and consequences of delay in diagnosis","volume":"100","author":"Kariyawasan","year":"2007","journal-title":"QJM"},{"key":"2026062404523989700_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41408-023-00961-0","article-title":"Addressing the disparities: the approach to the African American patient with multiple myeloma","volume":"13","author":"Bhutani","year":"2023","journal-title":"Blood Cancer J"},{"key":"2026062404523989700_bib5","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1182\/blood.V124.21.1294.1294","article-title":"Current state of patient awareness and participation in care for multiple myeloma and the psychophysical impact of treatment: an international internet-based study","volume":"124","author":"Ailawadhi","year":"2014","journal-title":"Blood"},{"key":"2026062404523989700_bib6","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3390\/diagnostics15131708","article-title":"Challenges, difficulties, and delayed diagnosis of multiple myeloma","volume":"15","author":"Zorlu","year":"2025","journal-title":"Diagnostics"},{"issue":"Supplement 1","key":"2026062404523989700_bib7","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2021-150848","article-title":"An in depth analysis of factors contributing to diagnostic delay in myeloma: a retrospective UK study of patients journey from primary care to specialist secondary care","volume":"138","author":"Hossain","year":"2021","journal-title":"Blood"},{"key":"2026062404523989700_bib8","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1038\/bcj.2017.97","article-title":"Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10\u201349 years old: a population-based study from the National Health and Nutrition Examination Survey","volume":"7","author":"Landgren","year":"2017","journal-title":"Blood Cancer J"},{"key":"2026062404523989700_bib9","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/d41586-020-03227-y","article-title":"The screening imperative for multiple myeloma","volume":"587","author":"Rajkumar","year":"2020","journal-title":"Nature"},{"key":"2026062404523989700_bib10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"2026062404523989700_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jamainternmed.2024.8124","article-title":"Diagnosis and management of monoclonal gammopathy of undetermined significance: a review","volume":"185","author":"Liu","year":"2025","journal-title":"JAMA Intern Med"},{"key":"2026062404523989700_bib12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41375-019-0419-7","article-title":"Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma","volume":"33","author":"Goyal","year":"2019","journal-title":"Leukemia"},{"key":"2026062404523989700_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41408-018-0077-4","article-title":"Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria","volume":"8","author":"Lakshman","year":"2018","journal-title":"Blood Cancer J"},{"key":"2026062404523989700_bib14","doi-asserted-by":"crossref","first-page":"e7297","DOI":"10.1002\/cam4.7297","article-title":"\u201cThe don\u2019t care to study it\u201d: trust, race and health care experiences among patient-caregiver dyads with multiple myeloma","volume":"13","author":"Grant","year":"2024","journal-title":"Cancer Med"},{"key":"2026062404523989700_bib15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1300439","article-title":"Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma","volume":"369","author":"Mateos","year":"2013","journal-title":"N Engl J Med"},{"key":"2026062404523989700_bib16","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1200\/JCO.19.01740","article-title":"Randomized trial of lenalidomide versus observation in smoldering multiple myeloma","volume":"38","author":"Lonial","year":"2020","journal-title":"J Clin Oncol"},{"key":"2026062404523989700_bib17","article-title":"iStopMM: investigators from Iceland report first results of population-based screening for multiple myeloma","author":"Caffrey","year":"2021"},{"issue":"Supplement 1","key":"2026062404523989700_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood-2021-152333","article-title":"Screening for monoclonal gammopathy of undetermined significance: a population-based randomized clinical trial. First results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study","volume":"138","author":"Kristinsson","year":"2021","journal-title":"Blood"},{"key":"2026062404523989700_bib19","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"2026062404523989700_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood.2024027065","article-title":"Is it time to screen for multiple myeloma","volume":"145","author":"Ghobrial","year":"2025","journal-title":"Blood"},{"key":"2026062404523989700_bib21","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.gim.2021.12.006","article-title":"Self-rated family health history knowledge among All of Us program participants","volume":"24","author":"Hull","year":"2022","journal-title":"Genet Med"},{"key":"2026062404523989700_bib22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.4143\/crt.2018.464","article-title":"Development of Protocol for Korean Lung Cancer Screening Project (K-LUCAS) to evaluate effectiveness and feasibility to implement National Cancer Screening Program","volume":"51","author":"Lee","year":"2019","journal-title":"Cancer Res Treat"},{"key":"2026062404523989700_bib23","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.2007-2222","article-title":"Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program","volume":"122","author":"Chien","year":"2008","journal-title":"Pediatrics"},{"key":"2026062404523989700_bib24","volume-title":"Predicting progression of developing myeloma in a high-risk screened population (PROMISE). ClinicalTrials.gov ID NCT03689595","author":"National Library of Medicine","year":"2018"},{"key":"2026062404523989700_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11894-020-00776-0","article-title":"Barriers driving racial disparities in colorectal cancer screening in African Americans","volume":"22","author":"White","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"key":"2026062404523989700_bib26","first-page":"183","article-title":"Cultural barriers to cancer screening among African American women: a critical review of the qualitative literature","volume":"3","author":"Hoffman-Goetz","year":"1997","journal-title":"Womens Health"},{"key":"2026062404523989700_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-244X-12-36","article-title":"Development and psychometric properties the Barriers to Access to Care Evaluation scale (BACE) related to people with mental ill health","volume":"12","author":"Clement","year":"2012","journal-title":"BMC Psychiatry"},{"key":"2026062404523989700_bib28","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/OP.24.00188","article-title":"Cancer prevention for women experiencing homelessness: onsite mammography, navigation, and education","volume":"20","author":"Hurwitz","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"2026062404523989700_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/jwh.2010.2195","article-title":"Patient barriers to mammography identified during a reminder program","volume":"20","author":"Feldstein","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"2026062404523989700_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/jwh.2017.6441","article-title":"Questions about cervical and breast cancer screening knowledge, practice, and outcomes: a review of demographic and health surveys","volume":"26","author":"Viens","year":"2017","journal-title":"J Womens Health (Larchmt)"},{"key":"2026062404523989700_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1557988311425853","article-title":"Gender differences in cancer screening beliefs, behaviors, and willingness to participate: implications for health promotion","volume":"6","author":"Davis","year":"2012","journal-title":"Am J Mens Health"},{"issue":"Supplement 1","key":"2026062404523989700_bib32","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1182\/blood-2024-210614","article-title":"A pilot screening and patient navigation program for early detection of multiple myeloma to address cancer disparities","volume":"144","author":"Basali","year":"2024","journal-title":"Blood"},{"issue":"12_Supplement","key":"2026062404523989700_bib33","doi-asserted-by":"crossref","first-page":"C115","DOI":"10.1158\/1538-7755.DISP23-C115","article-title":"Framework for a community-based multiple myeloma screening program","volume":"32","author":"Hurwitz","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026062404523989700_bib34","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/leu.2011.368","article-title":"Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites","volume":"26","author":"Greenberg","year":"2012","journal-title":"Leukemia"},{"key":"2026062404523989700_bib35","first-page":"785","article-title":"Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting","volume":"116","author":"Singh","year":"1990","journal-title":"J Lab Clin Med"},{"key":"2026062404523989700_bib36","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1038\/s41467-023-41223-8","article-title":"Disentangling age, gender, and racial\/ethnic disparities in multiple myeloma burden: a modeling study","volume":"14","author":"Huber","year":"2023","journal-title":"Nat Commun"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-26-0056\/3801287\/crc-26-0056.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/6\/1486\/3805974\/crc-26-0056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/6\/1486\/3805974\/crc-26-0056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:52:46Z","timestamp":1782291166000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/6\/1486\/786138\/Multiple-Myeloma-Screening-Education-A-Community"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-26-0056","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.32779812","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32779803","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32779815","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32779818","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32779806","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32779809","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8555559","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}